Search Results - "PRIETO, Peter A"

Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment by Mills, Bradley N., Connolly, Kelli A., Ye, Jian, Murphy, Joseph D., Uccello, Taylor P., Han, Booyeon J., Zhao, Tony, Drage, Michael G., Murthy, Aditi, Qiu, Haoming, Patel, Ankit, Figueroa, Nathania M., Johnston, Carl J., Prieto, Peter A., Egilmez, Nejat K., Belt, Brian A., Lord, Edith M., Linehan, David C., Gerber, Scott A.

“…Over 80% of pancreatic ductal adenocarcinoma (PDA) patients are diagnosed with non-resectable late-stage disease that lacks effective neoadjuvant therapies…”
Get full text

Thinking Small: Small Molecules as Potential Synergistic Adjuncts to Checkpoint Inhibition in Melanoma by Chacon, Alexander C, Melucci, Alexa D, Qin, Shuyang S, Prieto, Peter A

“…Metastatic melanoma remains the deadliest form of skin cancer. Immune checkpoint inhibition (ICI) immunotherapy has defined a new age in melanoma treatment,…”
Get full text

CD8+ Enriched Young Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma by DUDLEY, Mark E, GROSS, Colin A, RESTIFO, Nicholas P, WUNDERLICH, John R, PRIETO, Peter A, HONG, Jenny J, LANGAN, Russell C, ZLOTT, Daniel A, MORTON, Kathleen E, WHITE, Donald E, LAURENCOT, Carolyn M, ROSENBERG, Steven A, LANGHAN, Michelle M, GARCIA, Marcos R, SHERRY, Richard M, YANG, James C, PHAN, Giao Q, KAMMULA, Udai S, HUGHES, Marybeth S, CITRIN, Deborah E

“…Tumor-infiltrating lymphocytes (TIL) and interleukin (IL)-2 administered following lymphodepletion can cause the durable complete regression of bulky…”
Get full text

Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care by Qin, Shuyang S, Melucci, Alexa D, Chacon, Alexander C, Prieto, Peter A

“…Adoptive cell therapy (ACT) with tumor-infiltrating T cells (TILs) has emerged as a promising therapy for the treatment of unresectable or metastatic solid…”
Get full text

Reconstruction of Pharyngolaryngeal Defects with the Ileocolon Free Flap: A Comprehensive Review and How to Optimize Outcomes by Escandón, Joseph M., Santamaría, Eric, Prieto, Peter A., Duarte-Bateman, Daniela, Ciudad, Pedro, Pencek, Megan, Langstein, Howard N., Chen, Hung-Chi, Manrique, Oscar J.

“…Abstract Several reconstructive methods have been reported to restore the continuity of the aerodigestive tract following resection of pharyngeal and…”
Get full text

Commentary: Reconstruction of Pharyngolaryngeal Defects with the Ileocolon Free Flap: A Comprehensive Review and How to Optimize Outcomes by Escandón, Joseph M, Santamaría, Eric, Prieto, Peter A, Duarte-Bateman, Daniela, Ciudad, Pedro, Pencek, Megan, Langstein, Howard N, Chen, Hung-Chi, Manrique, Oscar J

Get full text

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma by Mooradian, Meghan J., Reuben, Alexandre, Prieto, Peter A., Hazar-Rethinam, Mehlika, Frederick, Dennie T., Nadres, Brandon, Piris, Adriano, Juneja, Vikram, Cooper, Zachary A., Sharpe, Arlene H., Corcoran, Ryan B., Flaherty, Keith T., Lawrence, Donald P., Wargo, Jennifer A., Sullivan, Ryan J.

“…Background: Approximately 50% of melanomas harbor BRAF mutations. Treatment with BRAF +/− MEK inhibition is associated with favorable changes in the tumor…”
Get full text

Commentary: 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration by Prieto, Peter A

Get full text

RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database by Prieto, Peter A., Goldberg, Matthew S., Martin, Brian

Get full text

Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience by Christakis, Ioannis A., MD, Potylchansky, Elena, MD, Silva, Angelica M., MD, Nates, Joseph P., MD, Prieto, Peter A., MD, Graham, Paul H., MD, Grubbs, Elizabeth G., MD, Lee, Jeffrey E., MD, Perrier, Nancy D., MD

“…Background Airway compromise from postoperative neck hematoma remains the most feared complication after cervical endocrine operative procedures. Events are…”
Get full text

RE: A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma by Prieto, Peter A., Goldberg, Matthew S., Martin, Brian

Get full text

COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma by Prieto, Peter A, Mannava, Kathleen, Sahasrabudhe, Deepak M

Get full text

Reconstruction of Pharyngolaryngeal Defects with the Ileocolon Free Flap: A Comprehensive Review and How to Optimize Outcomes by Escandon, Joseph M, Santamaria, Eric, Prieto, Peter A, Duarte-Bateman, Daniela, Ciudad, Pedro, Pencek, Megan, Langstein, Howard N, Chen, Hung-Chi, Manrique, Oscar J

“…Several reconstructive methods have been reported to restore the continuity of the aerodigestive tract following resection of pharyngeal and hypopharyngeal…”
Get full text

H-Scan Discrimination for Tumor Microenvironmental Heterogeneity in Melanoma by Baek, Jihye, Qin, Shuyang S, Prieto, Peter A, Parker, Kevin J

“…Melanoma is a form of malignant skin cancer that exhibits significant inter-tumoral differences in the tumor microenvironment (TME) secondary to genetic…”
Get full text

CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma by PRIETO, Peter A, YANG, James C, SHERRY, Richard M, HUGHES, Marybeth S, KAMMULA, Udai S, WHITE, Donald E, LEVY, Catherine L, ROSENBERG, Steven A, PHAN, Giao Q

“…Treatment with ipilimumab can cause objective tumor responses in patients with metastatic melanoma. We have treated 177 evaluable patients in three clinical…”
Get full text

Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes by FRIEDMAN, Kevin M, PRIETO, Peter A, DEVILLIER, Laura E, GROSS, Colin A, YANG, James C, WUNDERLICH, John R, ROSENBERG, Steven A, DUDLEY, Mark E

Get full text

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial by Amaria, Rodabe N, Prieto, Peter A, Tetzlaff, Michael T, Reuben, Alexandre, Andrews, Miles C, Ross, Merrick I, Glitza, Isabella C, Cormier, Janice, Hwu, Wen-Jen, Tawbi, Hussein A, Patel, Sapna P, Lee, Jeffrey E, Gershenwald, Jeffrey E, Spencer, Christine N, Gopalakrishnan, Vancheswaran, Bassett, Roland, Simpson, Lauren, Mouton, Rosalind, Hudgens, Courtney W, Zhao, Li, Zhu, Haifeng, Cooper, Zachary A, Wani, Khalida, Lazar, Alexander, Hwu, Patrick, Diab, Adi, Wong, Michael K, McQuade, Jennifer L, Royal, Richard, Lucci, Anthony, Burton, Elizabeth M, Reddy, Sangeetha, Sharma, Padmanee, Allison, James, Futreal, Phillip A, Woodman, Scott E, Davies, Michael A, Wargo, Jennifer A

“…Dual BRAF and MEK inhibition produces a response in a large number of patients with stage IV BRAF-mutant melanoma. The existing standard of care for patients…”
Get full text

Endocrine incidentalomas by Starker, Lee F., MD, PhD, Prieto, Peter A., MD, MPH, Liles, J. Spencer, MD, Tan Cao, Hop S., MD, Grubbs, Elizabeth G., MD, MS, Lee, Jeffrey E., MD, Perrier, Nancy D., MD, Graham, Paul H., MD

Get full text

Two-Stage Implant-Based Breast Reconstruction Using Intraoperative Fluorescence Imaging: A Propensity Score-Matched Analysis by Escandón, Joseph M., Christiano, Jose G., Gooch, Jessica C., Olzinski, Ann Therese, Prieto, Peter A., Skinner, Kristin A., Langstein, Howard N., Manrique, Oscar J.

“…Limited comparability between study groups can generate significant selection and observer bias when evaluating the efficacy of the SPY system and fluorescence…”
Get full text

Liver directed therapy for renal cell carcinoma by Langan, Russell C, Ripley, R Taylor, Davis, Jeremy L, Prieto, Peter A, Datrice, Nicole, Steinberg, Seth M, Bratslavsky, Gennady, Rudloff, Udo, Kammula, Udai S, Stojadinovic, Alexander, Avital, Itzhak

“…Metastatic renal cell carcinoma (RCC) to the liver portrays a poor prognosis and liver directed therapy remains controversial. We aimed to determine potential…”
Get full text